• Media
• News Releases
  • By Year
    • 2010
    • 2009
    • 2008
    • 2007
    • 2006
    • 2005
    • 2004
• Media Resources
  • Corporate
  • Central Nervous System Disorders
  • Cancer
  • Pain
• Featured Profiles
  • Healthcare Professionals
  • Programs
  • Products
• On The Record
  • Cephalon Response to JAMA Article “The Effects of Modafinil on Dopamine and Dopamine Transporters in the Male Human Brain”
  • Archive
    • Q&A on Settlements Regarding Investigations into Cephalon Business Practices
    • Our Commitment to Appropriate Interactions with Healthcare Professionals
    • Our Position on Tamper-Deterrent Formulation of Extended-Release Opioids
    • Set the Record Straight About ACTIQ®
    • Set the Record Straight About PROVIGIL®

Home > Media > Media Resources > Central Nervous System Disorders

Central Nervous System Disorders

NUVIGIL^® Press Kit

• Prescribing Information
• Press Releases
• NUVIGIL Fact Sheet

Multimedia Files

• NUVIGIL Photo (pdf)

Background Documents

• Drug Scheduling Fact Sheet
• Disease States Fact Sheets

PROVIGIL^® Press Kit

• Prescribing Information
• Press Releases
• PROVIGIL Fact Sheet
• Cephalon Response to JAMA Article, “The Effects of Modafinil on Dopamine and Dopamine Transporters In The Male Human Brain”

Multimedia Files

• PROVIGIL photo low res (.jpg)
• PROVIGIL photo high res (.jpg)

GABITRIL^® Press Kit

• Prescribing Information
• GABITRIL Fact Sheet

Background Documents

• Disease State Fact Sheet